Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.53 |
| ▸ | S100B | P04271 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL994961 | 1.00 | MAOB (0.66) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL992774 | 0.88 | CA1 (0.71) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL992775 | 0.88 | CA1 (0.71) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL10719675 | 0.87 | MAOB (0.64) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL10567450 | 0.86 | MAPT (0.72) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL10567452 | 0.86 | MAPT (0.72) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL13385757 | 0.84 | MAOB (0.62) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL13385780 | 0.84 | MAOB (0.62) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL13385758 | 0.84 | MAOB (0.62) | MAOBMAPTALDH1A1GAAMEN1 | |
| SCHEMBL18763297 | 0.84 | MAPT (0.67) | MAOBMAPTALDH1A1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8519069-B2 | Catalytic complex for olefin metathesis reactions, process for the preparation thereof and use thereof | RIMTEC CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| EP-2280017-B1 | Catalytic complex for olefin metathesis reactions, process for the preparation thereof and use thereof | RIMTEC CORP (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20120271019-A1 | CATALYTIC COMPLEX FOR OLEFIN METATHESIS REACTIONS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | TELENE S.A.S. (FR) | 2012-10-25 | — | — | US | disclosed |
| EP-2280017-A1 | Catalytic complex for olefin metathesis reactions, process for the preparation thereof and use thereof | Telene SAS (FR) | 2011-02-02 | — | — | EP | disclosed |
| WO-2011009721-A1 | CATALYTIC COMPLEX FOR OLEFIN METATHESIS REACTIONS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | TELENE S.A.S. (FR) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120271019-A1 | CATALYTIC COMPLEX FOR OLEFIN METATHESIS REACTIONS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | COASY, POR, DHPS | MAOB 48/4885MAPT 3177/4885ALDH1A1 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.